Related Business Topics
Latest Headlines
Reuters - Nov. 18, 2009, 5:59 AM
Champions Continues to Build its Tumorgraft(TM) Driven Oncology Pipeline BALTIMORE, Nov. 18 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), an oncology drug development company with a predictive preclinical platform ...
Forbes.com - Nov. 12, 2009, 6:52 AM
BALTIMORE A poster will be presented by Dr. Elizabeth Bruckheimer, Champions' Vice President for Scientific Operations, which will detail the Biomerk Tumorgraft(TM) platform and its characterization. Together the results demonstrate that by maintaining ...
